Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study
NCT ID: NCT05145738
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2021-12-23
2022-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To this end, the investigators propose a two-arm randomized controlled trial, randomizing up to 90 individuals with tobacco use to the current CRAVEN program which includes a virtual counselor, to CRAVEN without a virtual counselor. Primary outcomes include intervention feasibility and acceptability. The investigators will secondarily examine uptake and maintenance of pharmacotherapy for tobacco cessation, readiness to quit smoking, and tobacco cessation (7 day abstinence) at 6 months, patient satisfaction by intervention arm and CHW engagement by intervention arm.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
NCT07220356
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
NCT06545669
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
NCT06289192
Computer Delivered and Community Health Worker Supported Smoking Cessation Intervention
NCT04566159
Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology
NCT04172623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
C-Raven + Avatar
Computer delivered intervention with Avatar as virtual counselor plus linkage to community health worker
C-Raven with avatar
Computer delivered intervention with the investigators' avatar; with linkage to community health worker.
C-Raven
Computer-delivered intervention without virtual counselor, with linkage to community health worker
C-Raven without avatar
Computer delivered intervention without the investigators' avatar; with linkage to community health worker.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-Raven with avatar
Computer delivered intervention with the investigators' avatar; with linkage to community health worker.
C-Raven without avatar
Computer delivered intervention without the investigators' avatar; with linkage to community health worker.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current daily smoker and has smoked \>100 cigarettes in their lifetime
* English speaking
* Cognitively able to understand proposed research design
Exclusion Criteria
* Any contraindication to NRT use
* Hearing impaired (unable to listen to audio component of intervention)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geetanjali Chander
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Tobacco Treatment Clinic at Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00300496
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.